Quidel Corp. (NASDAQ:QDEL) dropped 4.2% during mid-day trading on Wednesday . The stock traded as low as $21.81 and last traded at $21.94, with a volume of 147,221 shares. The stock had previously closed at $22.91.

A number of equities research analysts have weighed in on QDEL shares. Raymond James Financial Inc. upgraded shares of Quidel Corp. from a “market perform” rating to an “outperform” rating and set a $21.50 price target on the stock in a research note on Monday, June 13th. Zacks Investment Research upgraded shares of Quidel Corp. from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a research note on Wednesday, July 13th. Finally, Canaccord Genuity reiterated a “hold” rating and set a $22.00 price target on shares of Quidel Corp. in a research note on Friday, July 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $21.58.

The stock’s 50-day moving average price is $21.84 and its 200 day moving average price is $18.86. The company’s market capitalization is $708.74 million.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/quidel-corp-qdel-shares-down-4-2.html

Quidel Corp. (NASDAQ:QDEL) last announced its quarterly earnings data on Wednesday, July 27th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.14. Quidel Corp. had a negative return on equity of 1.06% and a negative net margin of 6.59%. The company had revenue of $39.10 million for the quarter, compared to analysts’ expectations of $37.98 million. During the same quarter in the prior year, the business posted ($0.14) EPS. The business’s revenue was up 11.1% compared to the same quarter last year. Equities analysts anticipate that Quidel Corp. will post ($0.14) EPS for the current year.

In other news, CEO Douglas C. Bryant sold 2,832 shares of the company’s stock in a transaction that occurred on Tuesday, August 30th. The stock was sold at an average price of $22.00, for a total transaction of $62,304.00. Following the sale, the chief executive officer now owns 276,843 shares in the company, valued at approximately $6,090,546. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Robert Joseph Bujarski sold 22,057 shares of the company’s stock in a transaction that occurred on Tuesday, August 9th. The stock was sold at an average price of $22.58, for a total value of $498,047.06. Following the sale, the senior vice president now owns 60,100 shares in the company, valued at approximately $1,357,058. The disclosure for this sale can be found here. Insiders own 23.40% of the company’s stock.

Large investors have recently made changes to their positions in the company. Norges Bank acquired a new stake in Quidel Corp. during the fourth quarter worth $8,736,000. Macquarie Group Ltd. boosted its stake in Quidel Corp. by 27.7% in the second quarter. Macquarie Group Ltd. now owns 858,387 shares of the company’s stock worth $15,331,000 after buying an additional 186,020 shares during the period. Renaissance Technologies LLC boosted its stake in Quidel Corp. by 44.7% in the first quarter. Renaissance Technologies LLC now owns 300,500 shares of the company’s stock worth $5,187,000 after buying an additional 92,813 shares during the period. Baird Financial Group Inc. boosted its stake in Quidel Corp. by 34.2% in the second quarter. Baird Financial Group Inc. now owns 300,847 shares of the company’s stock worth $5,373,000 after buying an additional 76,639 shares during the period. Finally, Kennedy Capital Management Inc. acquired a new stake in Quidel Corp. during the first quarter worth $1,012,000. Institutional investors own 94.28% of the company’s stock.

About Quidel Corp.

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers.

5 Day Chart for NASDAQ:QDEL

Receive News & Ratings for Quidel Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel Corp. and related companies with MarketBeat.com's FREE daily email newsletter.